SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

Brera Holdings PLC

Brera Holdings (BREA) is trending due to news of a $300M private placement to fund a Solana digital asset treasury, leading to a rebrand as Solmate. Community members are actively discussing the potential for a significant price increase, drawing comparisons to other high-flying treasury plays and low float runners. The focus is on its potential within the decentralized finance space and the backing from Ark Invest and UAE investors.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending following news of a $5 billion investment and partnership with Nvidia to develop AI and PC products, which has sparked significant community discussion around the potential impact on Intel's market position and future growth. The community is weighing the significance of this deal, analyzing potential price movements, and evaluating the long-term implications for Intel and its competitors. Some investors suggest this marks a turning point for the company, while others express skepticism about Intel's ability to execute its turnaround strategy.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending amid anticipation of potential rate cuts, which are expected to boost the fintech company's lending business and overall valuation. The community is discussing whether the stock is poised for new all-time highs and potential S&P 500 inclusion, while some traders are weighing short-term profit-taking versus long-term growth prospects.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending due to concerns around Nvidia's investment in Intel, with the community debating the potential impact on AMD's competitive position. Many believe this is a strategic move acknowledging AMD's strength, while others worry about increased competition in both the CPU and GPU markets. Despite the uncertainty, some investors view the dip as a buying opportunity, citing AMD's strong fundamentals and future growth potential.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co.

Disney's stock is trending amidst discussions around political polarization and its impact on the company, particularly concerning content choices and perceived bias. Community members are debating the company's direction and whether recent decisions will affect subscription rates and overall profitability. Some investors see the current situation as a buying opportunity, while others express concerns about the company's long-term prospects.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as the quantum computing sector gains momentum, fueled by news of government contracts and partnerships. The community is discussing the company's technology, potential for growth, and comparisons to sector peers, along with speculation about future price targets and potential acquisitions. Some traders are expressing caution due to the high valuation compared to current revenue.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending amid excitement surrounding its potential to power AI data centers and a recent partnership with ABB. Community discussions revolve around the company's innovative technology and the future of nuclear energy, with some expressing concerns about its current valuation and pre-revenue status. The stock's surge is attributed to a US-UK nuclear pact and overall clean energy boom, though some caution a correction may be on the horizon.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as discussions revolve around potential partnerships, particularly with Panasonic and possibly Tesla, following Panasonic's announcement of anode-free solid-state batteries. The community is speculating about the implications of these developments for QS's technology and future OEM deals, while also debating short squeeze opportunities. Some traders believe the recent price action suggests institutional accumulation and anticipate further upside potential.

MicroAlgo, Inc. operates as a holding company, which engages in the development and application of bespoke central processing algorithms. Its services include algorithm optimization, accelerating computing power without the need for hardware upgrades, lightweight data processing, and data intelligence. The company was founded May 14, 2018 and is headquartered in New York, NY.

MicroAlgo Inc

MicroAlgo ($MLGO) is experiencing increased interest amid discussions of a potential short squeeze, driven by its low float and high short interest. The community is weighing the potential for significant upward movement against the risks associated with the stock's volatility and ties to Chinese firms. Traders are closely monitoring key resistance levels, anticipating a breakout or pullback.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as investors discuss its potential pivot towards AI and high-performance computing, fueled by recent CEO comments. Community members are actively watching key resistance levels and highlighting the stock's undervaluation compared to peers like IREN and CIFR. Bullish sentiment is building, with some anticipating a short squeeze and significant upside if the company successfully executes its new strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. equities declined in Tuesday’s midday trade, with the crucial two-day Federal Open Market Committee (FOMC) meeting currently underway.Ahead of the release of the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-meeting-date-fomc-rate-decision-when-announce-what-to-expect/chwynHURdzn">Fed meeting's outcome</a>, President Donald Trump&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-fed-should-be-independent-should-listen-to-smart-people-like-me/chwylmVRdzX">called on</a> the central bank to listen to “smart people” like himself, while stating that the central bank should remain independent.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was down 0.16% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq, fell 0.11%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, declined 0.26%.Here are the top stocks making the biggest moves in Tuesday’s midday trade:<a href="https://stocktwits.com/symbol/BBAI">BigBear.ai Holdings Inc. (BBAI)</a>BigBear.ai shares were up more than 15% in Tuesday’s midday trade after a recent&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bigbear-sparks-retail-buzz-as-congressional-disclosure-fuels-federal-win-rumor/chwy743RdyX">disclosure</a> by Representative Lisa McClain (R-Mich.) regarding the purchase of BBAI stock worth between $15,000 and $50,000 as part of a 401K account held with Charles Schwab. BigBear.ai was the top trending stock on Stocktwits at the time of writing.<a href="https://stocktwits.com/symbol/BBAI">BBAI stock</a> is up 32% year-to-date.<a href="https://stocktwits.com/symbol/TSLA">Tesla Inc. (TSLA)</a>Tesla shares continued to rise, gaining nearly 3% in Tuesday’s midday session following a surge on Monday after co-founder and CEO Elon Musk&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/tesla-shares-surge-elon-musk-purchases-stock-first-time-since-2020/chwwIvpRdUG">acquired</a> 2.57 million shares of the company on Friday, at an aggregate value of nearly $1 billion.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> is up 4% year-to-date.<a href="https://stocktwits.com/symbol/HIMS">Hims &amp; Hers Health Inc. (HIMS)</a>Hims &amp; Hers Health shares dropped by over 7% in Tuesday’s midday trade after the U.S. Food and Drug Administration (FDA)&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/hims-and-hers-stock-tumbles-7-percent-after-fda-letter/chwyNFWRdzV">sent</a> a letter alleging that the company’s claims concerning compounded Semaglutide products, used for weight loss, are “false or misleading.”<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> is up 109% year-to-date.<a href="https://stocktwits.com/symbol/RKLB">Rocket Lab Corp. (RKLB)</a>Rocket Lab shares dropped over 12% in Tuesday’s midday session after the company&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rocket-lab-stock-tumbles-10-percent-today-here-is-what-happened/chwyZ66Rdzl">announced</a> a $750 million at-the-market (ATM) equity offering.<a href="https://stocktwits.com/symbol/RKLB">RKLB stock</a> is up 87% year-to-date.<a href="https://stocktwits.com/symbol/WBD">Warner Bros. Discovery Inc. (WBD)</a>Warner Bros. Discovery shares fell over 8% in Tuesday’s midday trade after analysts at TD Cowen downgraded the stock to ‘Hold’ from ‘Buy’ on concerns that “there would be a lot of hurdles” in Paramount Skydance Corp.’s (PSKY)&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/paramount-skydance-reportedly-plans-majority-cash-bid-for-warner-bros-discovery/chwNp8zRdvx">reported</a> bid to acquire the former, according to TheFly. Senator Elizabeth Warren on Tuesday also voiced her disapproval, calling to block the deal, and said in a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/ewarren/status/1967936711264272677">post</a> on X that it “would be a dangerous concentration of power over our media and news.”<a href="https://stocktwits.com/symbol/WBD">WBD stock</a> is up 69% year-to-date.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-meeting-date-fomc-rate-decision-when-announce-what-to-expect/chwynHURdzn">Fed Meeting Date: Here's When FOMC's Rate Decision Will Be Announced, And What You Should Expect</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

BigBear.ai, Tesla, Hims & Hers, Rocket Lab, Warner Bros Discovery: Stocks Making The Biggest Moves Today

BigBear.ai shares were up more than 15% on Tuesday after a recent disclosure by Representative Lisa McClain regarding the purchase of BBAI stock worth between $15,000 and $50,000.

Equity

Shares of Hims &amp; Hers Health (HIMS) slumped 7% on Tuesday after the U.S. Food and Drug Administration (FDA) sent a letter to the company CEO regarding the sale of compounded drug products.In the letter <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-09092025">dated</a> September 9, the agency alleged that the company’s claims concerning compounded Semaglutide products, used for weight loss, are “false or misleading.” The FDA also noted that this is a violation of certain sections of the Federal Food, Drug, and Cosmetic Act.The FDA pointed out that compounded drug products are not approved by it. “Your claims imply that your products are the same as an FDA-approved product when they are not,” the letter said, while urging the company to take immediate action to address violations. A failure to adequately address any violation may result in legal action without further notice, it added.The FDA further alleged that these compounded products are misbranded and noted that the introduction of misbranded products into interstate commerce is prohibited. While the letter referred to two claims made on compounded Semaglutide products made on Hims’ website, it does not represent an exhaustive list of misbranding violations, the agency said.The FDA has given CEO Andrew Dudum 15 working days from the receipt of the letter to provide a written response describing the steps taken to address violations or to provide reasoning and supporting information if he believes the company is not in violation.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> jumped from ‘bullish’ to 'extremely bullish' territory over the past 24 hours, while message volume stayed at ‘high’ levels.In June, Novo Nordisk (NVO) <a href="https://stocktwits.com/news-articles/markets/equity/hims-stock-plunges-after-novo-nordisk-ends-wegovy-partnership/chm55y3RR5v">said</a> that it is halting collaboration with Hims &amp; Hers for the sale of its blockbuster weight loss drug Wegovy, the key ingredient of which is Semaglutide. Novo said that Hims &amp; Hers failed to adhere to the law, which prohibits mass sales of compounded drugs. It further alleged that the telehealth operator is promoting and selling illegitimate, knockoff versions of Wegovy and has hence decided to halt the collaboration entered into in late April.Dudum, however, subsequently <a href="https://stocktwits.com/news-articles/markets/equity/hims-and-hers-hits-back-at-novo-nordisk-after-collaboration-end/chm5fs2RRd4">alleged</a> that Novo’s management is “misleading the public.” The CEO stated in a post on X that the pharmaceutical company’s commercial team has been pressuring the company to control clinical standards and steer patients toward Wegovy, regardless of whether it is clinically the best option for patients.HIMS stock has more than doubled its value this year and tripled over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/eli-lilly-to-set-up-5-billion-facility-in-virginia/chwymFcRdzj">Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Hims & Hers Health, Inc. is displayed on a smartphone screen on May 04, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Hims & Hers Stock Draws Investor Attention After Tumbling 7% – Here’s What Happened

In a letter dated September 9, the FDA alleged that the company’s claims concerning compounded Semaglutide products are “false or misleading.”

Hims & Hers Expands AI and Technology Focus to Advance Digital Care

HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.

Company News for Sep 16, 2025

Companies in The News Are: NVDA,HIMS,MSFT,NFLX

Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $54.03, signifying a -2.65% move from its prior day's close.

OMCL or HIMS: Which Is the Better Value Stock Right Now?

OMCL vs. HIMS: Which Stock Is the Better Value Option?

Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know

Hims & Hers Health (HIMS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?

HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.

The last few months have seen a resurgence in social media-driven stock trades,&nbsp;resulting in a crop of new meme stocks,&nbsp;including Opendoor, GoPro, Kohl's, and Krispy Kreme.Now, JPMorgan has identified a few more names to keep a tab on. "We are flagging a few stocks that are heavily mentioned on Social Media and have high Retail buying as well as high Hedge fund Shorting," the investment research said in a note to clients, according to<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/09/11/four-meme-stocks-with-high-social-activity-and-hedge-funds-shorts-according-to-jpmorgan.html">&nbsp;CNBC</a>. "These stocks may experience unexpected flows in case of increased activity."Here are JPMorgan's picks and brief notes on their recent moves:&nbsp;Hims &amp; Hers HealthThe weight loss and health management company's stock has fluctuated significantly between peaks and troughs. Earlier this year, the company entered into a partnership with Novo Nordisk to distribute the latter's Wegovy, a popular GLP-1 weight loss drug. However, a few months later, the Danish pharmaceutical major canceled the partnership, citing Hims &amp; Hers' failure to prevent "knockoff" compounded versions of Wegovy and for engaging in deceptive marketing.U.S. regulators have rapped Hims &amp; Hers for its drug marketing practices, and investors are closely watching the company's moves.Year-to-date gain: 110%Short interest: 31.1%Stocktwits sentiment:&nbsp;Bullish&nbsp;ImmunityBioThe cancer-focused biotech firm has seen interest, driven by clinical-stage Anktiva,&nbsp;designed to boost the immune system's tumor-fighting response, and&nbsp;immunotherapies that target and kill cancer cells. Although the company's stock has mostly&nbsp;traded rangebound this year, shares have jumped double-digit percentages on several occasions in reaction to positive trial data.Year-to-date gain: 0.4%Short interest: 8%Stocktwits sentiment:&nbsp;Bullish&nbsp;Rocket CompaniesThe mortgage and house-owning services firm has seen its stock climb steadily this year, with a recent bump accompanying renewed expectations of a potential lowering of interest rates. The stock hit a 52-week high earlier this week.In March, the Rocket Companies announced a massive $9.4-billion all-stock acquisition of competitor Mr. Cooper Group, lifting investor confidence. The company's business is closely tied to the housing market, which is experiencing a modest rebound.Year-to-date gain: 97%Short interest: 5.3%Stocktwits sentiment:&nbsp;Bullish&nbsp;SoundHound AIAfter a whopping 836% rise in 2024, SoundHound shares have traded comparatively sombrely this year. That said, several analysts have recently begun covering the company, impressed by its voice-based AI technology.In July, the company reported a 217% rise in its second-quarter revenue and increased its sales guidance for the whole year.Year-to-date loss: 29%Short interest: 28.7%Stocktwits sentiment:&nbsp;Bullish&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/rent-the-runway-stocks-plummets-27-after-hours-on-mounting-losses-surging-costs-retail-traders-still-bullish/chw8hPeRdwL">&nbsp;Rent The Runway Stocks Plummets 27% After-Hours On Mounting Losses, Surging Costs — Retail Traders Still Bullish</a>

Traders work on the floor of the New York Stock Exchange during morning trading on August 26, 2025, in New York City. 

Not Just Opendoor & GoPro: JPMorgan Identifies 4 Emerging 'Meme Stocks' Firing Up Social Media And Hedge Fund Shorts

Meme mania has resurged in the past few months.

Shares of Hims &amp; Hers Health, Inc. (HIMS) rose 3% on Wednesday after the telehealth company launched a new category in men’s health, offering access to innovative, affordable, and personalized treatment plans for low testosterone.The company estimates that over 20 million men in the U.S. struggle with low testosterone, but noted that most never receive care due to stigma, outdated treatments, and high costs.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> stayed within the ‘bullish’ territory over the past 24 hours while message volume rose from ‘normal’ to ‘high’ levels. According to Stocktwits data, retail chatter around the stock increased by 21% over the last 24 hours and by approximately 533% over the last 30 days as of the early hours on Wednesday.<figure class="image"><img style="aspect-ratio:624/61;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_10_at_12_36_35_PM_png_dcb797f889.webp" alt="HIMS's Sentiment Meter and Message Volume as of 12:36 p.m. ET on Sept. 10, 2025 | Source: Stocktwits" width="624" height="61"><figcaption>HIMS' Sentiment Meter and Message Volume as of 12:36 p.m. ET on Sept. 10, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user said that the stock continues to rally without offering a favorable entry point.<stembedurl>https://stocktwits.com/Canyonfundstrader2007/message/628171596</stembedurl>Hims <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.hims.com/news/news-details/2025/Hims-Launches-New-Category-in-Mens-Health-with-Exclusive-Branded-Oral-Testosterone-and-Expanded-Personalized-Treatments/default.aspx">said</a> on Wednesday that low testosterone, if left untreated, can drain energy, dull mood and sexual desire, and raise risks of heart disease, diabetes, and cancer. Starting in 2026, the company will launch a branded oral testosterone called Kyzatrex through a collaboration with Marius Pharmaceuticals. Kyzatrex is FDA-approved and has been shown to restore testosterone levels in up to 96% of men, Hims said.The company also stated that it will introduce access to injectable testosterone treatments in 2026. Providers will also be able to prescribe tailored doses of compounded Enclomiphene for men experiencing sexual symptoms through the Hims &amp; Hers platform starting Wednesday, the company said. Enclomiphene has been shown to double testosterone levels by restoring natural testosterone production, the company stated. Bloomberg <a href="https://stocktwits.com/news-articles/markets/equity/hims-and-hers-to-launch-low-testosterone-treatments-for-men-as-weight-loss-drug-sales-slow/chwjw9LRdt6">reported</a> that Hims will make the announcement earlier in the day.&nbsp;Separately, on Tuesday, the U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) announced a major reform of pharmaceutical advertisements, which will require drug companies to include full safety warnings in their direct-to-consumer ads.According to BofA analyst Allen Lutz, these industry changes are likely to make new customer conversions more challenging through ads, given the competitive pressures in the sexual health, hair loss, and weight loss sectors. Overall, Hims &amp; Hers should be able to navigate this environment given its strong brand equity and first-mover advantage, the analyst said, while adding that it would expect continued volatility in the near term.The firm kept an ‘Underperform’ rating on Hims &amp; Hers with a price target of $28 on the shares.HIMS stock has more than doubled in value this year and more than tripled over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/merck-reportedly-scraps-research-centre-in-uk/chwkKULRdut">Merck Reportedly Scraps Research Centre In UK: Retail Sees Stock Rallying To $97.50</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hims & Hers Stock Rises After Company Launches Treatment Plans For Low Testosterone

According to Stocktwits data, retail chatter around HIMS stock increased by 21% over the last 24 hours and by approximately 533% over the last 30 days as of the early hours on Wednesday.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

HIMS
Hims & Hers Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HIMS News

HIMS Hims & Hers Health Inc